This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by September 19 to save $600

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Manabu Wadamoto, PhD
Chief Scientist at Chugai Pharmaceutical Co., Ltd.
Speaker

Profile

Dr. Manabu Wadamoto is a Chief Scientist in the Medicinal Chemistry Research Department at Chugai Pharmaceutical Co., Ltd. After completing his Ph.D. at the University of Chicago (2006) under the supervision of Prof. Hisashi Yamamoto and postdoctoral work at Northwestern University with Prof. Karl A. Scheidt, he joined Mitsui Chemicals Asia Pacific in Singapore (2007). Since 2010, he has been with Chugai Pharmaceutical, where he leads discovery process chemistry efforts on small and medium-sized molecule projects.